ATTO — Attovia Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00- $661.94m
- $546.81m
- $1.35m
Annual cashflow statement for Attovia Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2024 December 31st | 2025 December 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | PROSPECTUS/A | PROSPECTUS/A |
| Standards: | USG | USG |
| Status: | Final | Final |
| Net Income/Starting Line | -39.8 | -60.6 |
| Depreciation | ||
| Non-Cash Items | 2.92 | 0.348 |
| Unusual Items | ||
| Other Non-Cash Items | ||
| Changes in Working Capital | 1.54 | 0.276 |
| Change in Prepaid Expenses | ||
| Change in Other Assets | ||
| Change in Accounts Payable | ||
| Change in Accrued Expenses | ||
| Cash from Operating Activities | -35 | -59.2 |
| Capital Expenditures | -1.77 | -2.31 |
| Purchase of Fixed Assets | ||
| Other Investing Cash Flow Items | -38 | -71.1 |
| Sale/Maturity of Investment | ||
| Purchase of Investments | ||
| Cash from Investing Activities | -39.8 | -73.5 |
| Financing Cash Flow Items | -0.019 | -0.376 |
| Other Financing Cash Flow | ||
| Net Issuance / Retirement of Stock | ||
| Net Issuance / Retirement of Debt | ||
| Cash from Financing Activities | 82.7 | 142 |
| Beginning Cash Balance | ||
| Ending Cash Balance | ||
| Net Change in Cash | 7.91 | 9.36 |